Literature DB >> 11870122

The value of Chlamydia trachomatis antibody testing in predicting tubal factor infertility.

L M W Veenemans1, P J Q van der Linden.   

Abstract

BACKGROUND: The objective of the present study was to compare the likelihood of abnormal Chlamydia trachomatis antibody test results with that of abnormal hysterosalpingography (HSG) test results in patients with tubal factor infertility.
METHODS: Anti-C. trachomatis immunoglobulin G antibodies were determined prospectively in 295 infertility patients by means of an indirect fluorescent antibody technique. In 48 of the 295 patients both HSG and laparoscopy with chromotubation were performed. The results of C. trachomatis antibody testing were compared with the results of HSG with respect to their predictive value of tubal factor infertility. Likelihood ratios for abnormal C. trachomatis antibody and HSG test results were determined in infertility patients, as assessed by laparoscopy.
RESULTS: The positive likelihood ratio for C. trachomatis antibody testing was 1.8. This was comparable with the HSG, which had a positive likelihood ratio of 1.7.
CONCLUSIONS: The predictive value of C. trachomatis antibody testing was equal to that of HSG, but ratios of 1.7 and 1.8 indicate a poor test, so both C. trachomatis antibody testing and HSG have a poor predictive value. C. trachomatis antibody testing causes minimal inconvenience to the patient, in contrast to HSG, and therefore should be maintained in infertility examinations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870122     DOI: 10.1093/humrep/17.3.695

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

Review 1.  Sexually transmitted diseases and infertility.

Authors:  Danielle G Tsevat; Harold C Wiesenfeld; Caitlin Parks; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2017-01       Impact factor: 8.661

2.  Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection.

Authors:  Nicole M Budrys; Siqi Gong; Allison K Rodgers; Jie Wang; Christopher Louden; Rochelle Shain; Robert S Schenken; Guangming Zhong
Journal:  Obstet Gynecol       Date:  2012-05       Impact factor: 7.661

3.  Association of the Serum Anti-chlamydial Antibodies with Tubal Infertility.

Authors:  Ashish Surana; Vijaylata Rastogi; Prem Singh Nirwan
Journal:  J Clin Diagn Res       Date:  2012-09-12

4.  Stimulated intrauterine insemination in women with unilateral tubal occlusion.

Authors:  Gwang Yi; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim
Journal:  Clin Exp Reprod Med       Date:  2012-06-30

5.  The prevalence and outcome of asymptomatic chlamydial infection screening among infertile women attending gynecological clinic in ibadan, South west Nigeria.

Authors:  Io Morhason-Bello; Oa Ojengbede; A Oladokun; Bo Adedokun; A Ajayi; Aa Adeyanju; O Ogundepo; Oi Kareem
Journal:  Ann Med Health Sci Res       Date:  2014-03

Review 6.  Female urogenital chlamydia: Epidemiology, chlamydia on pregnancy, current diagnosis, and treatment.

Authors:  Dian Tjahyadi; Bejo Ropii; Kevin Dominique Tjandraprawira; Ida Parwati; Tono Djuwantono; Wiryawan Permadi; Tinchiu Li
Journal:  Ann Med Surg (Lond)       Date:  2022-03-02

7.  Association between serum chlamydial antibody levels and tubal infertility in tertiary health facility in South-East Nigeria: a case-control study.

Authors:  Augustine D Onyeabochukwu; Emmanuel O Izuka; Onyema A Onyegbule; Chiemeka C Onumajuru; Uchenna T Ejelonu; Chukwunonyerem P Duke-Onyeabo; Chinelo E Obiora-Izuka; Uchenna I Nwagha
Journal:  Ghana Med J       Date:  2021-09

8.  The prevalence of serum immunoglobulin g antibody to Chlamydia trachomatis in subfertile women presenting at the university of port harcourt teaching hospital, Nigeria.

Authors:  Israel Jeremiah; Ola Okike; Chris Akani
Journal:  Int J Biomed Sci       Date:  2011-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.